Hybrid bioprinter creates capillary networks narrower than 10 micrometers

A groundbreaking advancement in biomedical engineering has emerged with the creation of a hybrid bioprinter capable of producing capillary networks narrower than 10 micrometers. This innovation, achieved through a collaborative effort led by Yanliang Zhang, an advanced materials and manufacturing professor at the University of Notre Dame, marks a critical milestone in the quest to develop fully functional lab-grown organs. The research was published in Nature Chemical Engineering and showcases a novel integration of 3D printing techniques combined with machine learning algorithms to achieve unprecedented precision in vascular structure replication. Currently, over 100,000 individuals in the United States await an organ transplant, with new candidates being added to the waiting list every ten minutes. Despite successful transplants, recipients face lifelong challenges, including the need for immunosuppressive drugs that increase infection risks and the constant threat of organ rejection. Bioprinting, which aims to create tissues and organs from a patient’s own cells, has long been considered a potential solution to these issues. However, one of the most persistent hurdles has been the accurate replication of the intricate vascular networks that supply oxygen and nutrients throughout the body. Capillaries, the smallest and most numerous blood vessels, play a crucial role in maintaining the viability of engineered tissues. Their ability to deliver life-sustaining substances to every cell makes them indispensable yet notoriously challenging to replicate in laboratory settings. Traditional bioprinting methods struggle to produce capillaries smaller than 10 micrometers, which are significantly thinner than a strand of human hair. This limitation has hindered progress toward creating complex, fully functional organs. Zhang and his team addressed this challenge by developing a hybrid bioprinting approach that combines two distinct 3D printing techniques. The process begins with the extrusion of a soft, gel-like scaffold designed to mimic the mechanical properties of native tissue. Once this base structure is formed, thin strands of gelatin are introduced using aerosol jet printing (AJP). These strands serve as temporary supports that are later removed, leaving behind hollow channels that simulate the internal structure of capillaries. A key innovation lies in the use of aerodynamic focusing, a feature inherent to AJP technology. By manipulating the flow of ink and surrounding gases, the researchers can dynamically adjust the dimensions of the printed channels, achieving resolutions ranging from hundreds of micrometers down to just a few micrometers. This level of control allows for the production of vascular structures that closely resemble those found in natural biological systems. To further enhance efficiency and accuracy, the team incorporated a machine learning framework into the printing process. This system automatically identifies and optimizes the ideal combination of printing parameters, such as ink flow rates and sheath gas velocities, for each target channel size. This integration significantly reduces the trial-and-error phase typically associated with bioprinting, enabling faster and more consistent results. The resulting vascular networks, composed of both one-dimensional, two-dimensional, and three-dimensional configurations, were successfully lined with living cells, demonstrating their potential for integration into larger tissue constructs. The success of this method represents a major leap forward in the field of regenerative medicine, bringing scientists closer to the goal of creating viable, transplantable organs in the laboratory. As the research continues, the focus will likely shift toward scaling up the technology and testing its effectiveness in more complex tissue models. With continued refinement, this hybrid bioprinting technique could revolutionize organ transplantation by offering a sustainable alternative to donor-based procedures.